Precision oncology using a limited number of cells: optimization of whole genome amplification products for sequencing applications

BACKGROUND: Sequencing analysis of circulating tumor cells (CTCs) enables “liquid biopsy” to guide precision oncology strategies. However, this requires low-template whole genome amplification (WGA) that is prone to errors and biases from uneven amplifications. Currently, quality control (QC) method...

Descripción completa

Detalles Bibliográficos
Autores principales: Sho, Shonan, Court, Colin M., Winograd, Paul, Lee, Sangjun, Hou, Shuang, Graeber, Thomas G., Tseng, Hsian-Rong, Tomlinson, James S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493892/
https://www.ncbi.nlm.nih.gov/pubmed/28666423
http://dx.doi.org/10.1186/s12885-017-3447-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493892/
https://www.ncbi.nlm.nih.gov/pubmed/28666423
http://dx.doi.org/10.1186/s12885-017-3447-6

Ejemplares similares